Open Access

Iron deficiency as a therapeutic target in heart failure - new evidence, new guidelines

Event: ESC Congress 2021 - The Digital Experience
Topic: Chronic Heart Failure
Session type: Satellite Symposium
Sponsored by Charité Friends & Sponsors Trust - Supported by an unrestricted educational grant from Vifor Pharma
Date: 30 August 2021
Time: 11:30 - 12:00

Session

This content is currently on OPEN ACCESS

Sign in to view the resources

5 presentations in this session

Welcome and introduction.

Speaker: Professor S. Anker (Berlin, DE)
Thumbnail

New evidence from AFFIRM-AHF ‒ implications for clinical practice.

Speaker: Professor P. Ponikowski (Wroclaw, PL)
Thumbnail

New evidence from meta-analyses ‒ lessons to learn on the benefits of intravenous ferric carboxymaltose in heart failure.

Speaker: Professor J. Butler (Jackson, US)
Thumbnail

Management of iron deficiency in heart failure - what do the guidelines say?

Speaker: Professor A. Coats (Coventry, GB)
Thumbnail

Panel discussion.

Thumbnail

4 speakers from this session

Professor Stefan Anker

Charite Campus Virchow Clinic, Berlin (Germany)
106 presentations
2 followers

Professor Piotr Ponikowski

Wroclaw Medical University, Wroclaw (Poland)
67 presentations
8 followers

Professor Javed Butler

University of Mississippi, Jackson (United States of America)
65 presentations
3 followers

Professor Andrew Coats

University of Warwick, Coventry (United Kingdom of Great Britain & Northern Ireland)
88 presentations
4 followers

Related content

ESC Premium Access

ESC Guidelines 2021 - Heart Failure

3 December 2021

ESC Premium Access

Trials Focus: GUIDE-HF / EMPEROR-Preserved

3 December 2021

ESC Premium Access

Current controversies in antithrombotic therapy

3 December 2021

This platform is supported by

logo Novo Nordisk